UMAN glioblastomas are extremely lethal neoplasms that respond poorly to current treatment strategies of cytoreductive neurosurgery, involvedfield radiotherapy, and adjuvant chemotherapy. Median survival for patients harboring these tumors lies in the range of 1 year, even in cases in which aggressive multimodal treatment is used. Neurological morbidity and, ultimately, death result from the locally infiltrative and destructive growth patterns of these tumors. Efforts to elucidate the molecular mechanisms responsible for migration and invasion of glioma cells-for example, in the rat gliosarcoma cell line C6-have therefore received increasing attention over the last few years. When compared with normal tissue, genes found to be expressed at increased levels in C6 cells are associated with cell-surface interactions, migration, or metastasis formation and proliferation. These include the receptor for hyaluronan-mediated motility. 8 Findings of several studies have confirmed interactions between the integrins expressed on glioma cells and the extracellular matrix and activity of metalloproteinases as prerequisites for the migration and invasion of glioma cells. 3, 7 More recently, enhanced expression of the antiapoptotic protein BCL-2 has been shown to promote glioma cell migration and invasiveness in a MMP-dependent manner. 24 The role that integrins, especially the vitronectin receptor ␣ V ␤ 3 , play in these processes remains controversial. 19 Inhibition of MMP activity is supposed to be a rational approach to glioma therapy. The potential therapeutic value of inhibiting MMP activity in human gliomas is underscored by the beneficial effects of inhibiting the expression of the UPA receptor, a putative positive upstream regulator of MMP activity, in rodent glioma models. 10 Similarly, forced therapeutic expression of TIMP-3, a putative inhibitor of MMP activity, has been shown to suppress infiltration and to induce apoptosis in cancer cell lines.
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Materials and Methods

Cell Lines and Cell Culture
We studied 12 human glioma cell lines that had been characterized in previous studies. 21 The cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, glutamine (2 mM), and penicillin (100 IU/ml)/streptomycin (100 g/ml).
Reverse Transcription-Polymerase Chain Reaction
Total cellular RNA was extracted using the RNeasy Kit. The RNA (5 g) was transcribed, following which it was digested using RNAse H. All PCRs were performed using Taq polymerase (5 U/ l) and 10 ϫ buffer for Taq polymerase containing MgCl 2 (1.5 mM final concentration). The PCR conditions are outlined in Table 1 . Negative controls for the PCRs consisted of aliquots containing water instead of cDNA. All PCRs were performed in a Robocycler, and ␤-actin served as a control to normalize for cDNA abundance.
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis Method and Immunoblot Analysis
The general procedure for this investigation was described previously. 21 The following primary antibodies were used at concentrations of 1 to 2 g/ml: mouse monoclonal anti-MMP-2, anti-MMP-3, anti-MMP-7, anti-MMP-9, anti-MT1-MMP, and anti-TIMP-2; mouse monoclonal anti-BCL2 and rabbit polyclonal anti-BAK and anti-BAX (N20); and mouse monoclonal anti-BCL-XL, anti-BAD, and anti-MCL-1. The protein bands were visualized using antimouse IgG or anti-rabbit IgG and the enhanced chemiluminescence system. 22 
Zymographic Study
The activities of MMP-2 and MMP-9 were analyzed using sodium dodecyl sulfate-polyacrylamide gels containing 0.1% gelatin (wt/vol) and 10% polyacrylamide (wt/vol). This assay is based on the digestion of gelatin by gelatinolytic enzymes. Coomassie brilliant blue staining and subsequent destaining with glacial acid results in decreased staining at the level of electrophoretic migration of MMP-2 and MMP-9 on the gel compared with the remainder of the gel. The cells were grown in 75-cm 2 culture flasks in Dulbecco's modified Eagle's medium containing 10% fetal calf serum until there was 80% confluency. The cells were washed and maintained in serum-free medium. Conditioned medium was collected at 48 hours. The medium was concentrated using Centriplus centrifuge filter devices. Volumes containing 20 g of protein were mixed with Laemmli sample buffer (minus reductant) in a 4:1 ratio prior to electrophoresis. Gels were run at a constant current, washed twice for 20 minutes in 50 mM Tris-HCl (pH 7.5) and 2.5% Triton X-100, and then incubated overnight at 37˚C in 50 mM Tris-HCl (pH 7.6) containing 10 mM CaCl 2 , 150 mM NaCl, and 0.05% NaN 3 . Gels were stained with Coomassie brilliant blue R-250 and then destained.
Migration Assay
Cell migration was measured using a chemotaxis chamber containing membranes with 8-m pores. The cells were cultured to confluency, trypsinized, and adjusted to 4 ϫ 10 5 cells/ml. The lower wells of the chamber were filled with 30 l of 3T3-conditioned medium, the membrane with 8-m pores was placed between the upper and lower wells, and 50 l of cell suspension was added in triplicate to the upper wells. After a 24-hour incubation, cells that had migrated through the pores to the lower side of the membrane were fixed and stained. Migration through the membranes was quantified by counting stained cells with the aid of a microgrid. In some assays a neutralizing ␣ V ␤ 3 integrin antibody (10 ng/ml) or a nonspecific mouse antibody was added to the cell suspensions 12 hours before the migration assays.
Matrigel Invasion Assay
Invasiveness was assessed by measuring glioma cell invasion through Matrigel-coated membranes. Membranes were coated with a final concentration of 0.78 mg/ml of Matrigel. The membrane was mounted in a chemotaxis chamber. To quantify invasion, we used the method described for the migration assay.
Flow Cytometry
Semiconfluent cells were trypsinized and 5 ϫ 10 5 cells/sample were pelleted and resuspended in 100 l of flow cytometry buffer (PBS containing 0.1% bovine serum albumin). Phycoerythrin-labeled ␣ V ␤ 3 antibody (1 l) was added. The control cells received 1 l of IgG isotype control. The samples were incubated in the dark for 30 to 45 minutes, washed twice with PBS, resuspended in 500 l PBS, and analyzed. Specific fluorescence indexes were calculated by dividing the geometric means of specific antibody-labeled cells by the geometric means of isotype control antibody-labeled cells.
Statistical Analysis
Interrelationships among invasion, migration, and ␣ V ␤ 3 expression were determined using the Pearson product-moment correlation. Protein levels were correlated using the Spearman rank-order correlation. A t-test was used to compare invasion, migration, and ␣ V ␤ 3 expression between two groups. Quantitative data were obtained for migration, invasion, ␣ V ␤ 3 expression and protein levels of MMP and BCL-2 homologs by using a densitometer and standard software. Probability values lower than 0.05 were considered significant.
Sources of Supplies and Equipment
The RNeasy Kit, purchased from Quiagen (Hilden, Germany), was used to extract total cellular RNA. The Superscript II was acquired from Gibco BRL (Paisley, UK) and the Oligo(dT)30 from Pharmacia-Biotech (Freiburg, Germany). The RNAse H was obtained from Eurogentec (Seraing, Belgium) and the Taq polymerase from Roche (Mannheim, Germany). Stratagene (La Jolla, CA) manufactured the Robocycler.
The mouse monoclonal anti-MMP-2, anti-MMP-3, anti-MMP-7, anti-MMP-9, anti-MT1-MMP, and anti-TIMP-2 were obtained from Oncogene (Cambridge, MA); the mouse monoclonal anti-BCL2 and the rabbit polyclonal anti-BAK and anti-BAX (N20) from Santa Cruz Biotechnology (Santa Cruz, CA); and the mouse monoclonal anti-BCL-XL, anti-BAD, and anti-MCL-1 from Pharmingen (San Diego, CA). The anti-mouse IgG, anti-rabbit IgG, and enhanced chemiluminescence system were purchased from Amersham Pharmacia Biotech (Freiburg, Germany). Amicon Millipore (Bedford, MA) provided the Centriplus centrifuge filter devices.
The chemotaxis chamber was acquired from Neuroprobe (Cabin John, MD) and the 8-m pore membranes from Nucleopore (Pleasanton, CA). Diff-Quik was purchased from Dade-Behring (Düdin-gen, Switzerland). The ␣ V ␤ 3 integrin antibody was obtained from Chemicon (Hofheim, Germany). The Matrigel and the FACScalibur fluorescence-activated cell sorter were provided by Becton Dickinson (Heidelberg, Germany).
Results
Human glioma cells express mmp mRNA and MMP protein and exhibit MMP-2 and MMP-9 proteolytic activities. The RT-PCR was used to assess the expression of mmp and mmp-related genes in 12 human malignant glioma cell lines ( Table 1 ). The frequencies of mRNA detection in these 12 cell lines were 11 for mmp-2, 10 for mmp-3, seven for mmp-7, six for mmp-9, and two for mmp-12 (Fig. 1A) . The upa mRNA was expressed in 11 of 12 cell lines, with a very faint signal in A-172 cells. The MMP-2 protein was detected in 11 cell lines, MMP-3 in two, MMP-7 in four, and MT1-MMP in all 12 cell lines. In nine of the 12 cell lines TIMP-2 was detected (Fig. 1B) . Densitometry of MT1-MMP, MMP-2, and TIMP-2 protein levels was performed. We found a positive correlation between MT1-MMP and MMP-2 and between MT1-MMP and TIMP-2, as well as between MMP-2 and TIMP-2 (r = 0.58, r = 0.61, and r = 0.64, respectively; p Ͻ 0.05). Corresponding with the immunoblot data, all cell lines except LN-308 exhibited MMP-2 activity on the zymogram. In addition, five of 12 cell lines exhibited MMP-9 gelatinolytic activity (Fig. 1C) . There was a good correlation between MMP-2 and MMP-9 protein expression (Fig. 1B ) and in vitro gelatinolytic activity shown on zymograms (Fig. 1C) .
Migration, Invasion, and ␣ V ␤ 3 Integrin Expression in Human Glioma Cell Lines
The migratory and invasive potentials of the glioma cell lines, as assessed by their ability to penetrate an uncoated or Matrigel-coated membrane, are summarized in Fig. 2 . There was a great deal of variation in the ability of glioma cells to migrate and invade in vitro. Migratory and invasive potentials demonstrated a strong correlation (r = 0.79, p Ͻ 0.01). Next, we assessed whether migration and invasion, as quantified in Fig. 2 , were related to the pro- Given the critical role of ␣ V ␤ 3 integrin in glioma cell migration, 4, 13 we next determined the expression of ␣ V and ␤ 3 mRNA by using RT-PCR (Fig. 3A) and the levels of ␣ V ␤ 3 integrin protein at the cell surface (Fig. 3B) . Both ␣ V and ␤ 3 mRNA were detected in all cell lines. The ␣ V ␤ 3 integrin protein levels at the cell surface were highly heterogeneous in these glioma cell lines. For instance, a high level of expression was detected in U87MG, LN-229, and LN-308 cells, whereas LN-319 and A172 cells were essentially negative. The levels of ␣ V ␤ 3 integrin expression were quantified by calculating the specific fluorescence indexes (Fig. 3C ) and related to the migratory and invasive potentials of the glioma cell lines. There was no correlation between ␣ V ␤ 3 integrin expression and migration or invasion. Importantly, migration and invasion in A172 and LN-319 cells was necessarily ␣ V ␤ 3 independent because these cell lines do not express ␣ V ␤ 3 integrin. To examine the role of ␣ V ␤ 3 in cell lines expressing high levels of this integrin, we performed migration and invasion assays in the absence or presence of a neutralizing ␣ V ␤ 3 integrin antibody ( Fig. 3D and E) . Consistent with the ␣ V ␤ 3 integrin expression data and with a critical role of this protein in migration and invasion of some cell lines, the neutralizing antibody strongly inhibited migration and invasion in cell lines with high levels of ␣ V ␤ 3 integrin expression such as U87MG, LN-229, and LN-308 but not in cell lines in which no expression was displayed, A172 and LN-319.
Protein Levels of the BCL-2 Family: Relationship With MMP, Migration, and Invasion
We previously reported that ectopic expression of a murine bcl-2 transgene enhanced the migration and invasion of LN-18 and LN-229 cells and that this effect was associated with an altered profile of MMP expression and activity. 24 In addition, an increased BCL-2/BAX ratio has been associated with a survival advantage of glioma cells at the tumor margin and protection of gliomas from apoptotic cell death. 18 Therefore, we sought to examine whether the BCL-2 family protein expression may be directly related to the promotion of infiltrative growth, rather than merely mediating resistance to apoptotic stimuli. We asked whether an assessment of endogenous BCL-2 family protein expression could allow us to predict the migratory and invasive potential of glioma cell lines. Although BCL-2 family protein expression was examined and reported 2 years ago, 21 we believed that it was necessary to reassess these data precisely with the cells that were used for the experiments reported herein. The levels for the antiapoptotic proteins BCL-2, BCL-XL, and MCL-1 were rather variable among the cell lines, as were the levels of the proapoptotic BAK and BAD proteins. In contrast, the proapoptotic BAX was expressed rather homogeneously (Fig. 4) . Using densitometric data, we determined ratios between pro-and antiapoptotic proteins and found a significant correlation between this ratio and both migration (r = 0.54, p Ͻ 0.05) and invasion (r = 0.56, p Ͻ 0.05) in the 12 cell lines. There was also a significant correlation of MMP-2 activity and antiapoptotic BCL-2 family protein expression (r = 0.61, p Ͻ 0.05). Moreover, correlation analysis revealed that MT1-MMP protein levels were inversely related to BAK protein expression (r = Ϫ0.58, p = 0.05). Cell lines expressing high levels of BAK were also less invasive (p = 0.02, t-test) and less migratory (p = 0.05, t-test). Although a relationship between the BCL-2/BAX ratio and the expression of ␣ V ␤ 3 integrin has been postulated for two cell lines, 13 our comprehensive analysis of 12 cell lines failed to demonstrate such a relation. No other link between BCL-2 family protein expression and migration, invasion, or ␣ V ␤ 3 integrin expression became apparent.
Status of p53 Modulates Migration of Glioma Cells
The p53 status of the cell lines examined has been reported. 21 The U87MG, D247MG, and U138MG cell lines have wild-type p53; the LN-229 cell line is heterozygous but exhibits functional p53 activity, and the status of p53 is therefore regarded as wild type in this study. The other eight cell lines have mutant or deleted p53. A comparison of wild-type p53 cell lines with mutant p53 cell lines revealed that wild-type p53 cell lines migrated better than mutant p53 cell lines (p = 0.04, t-test). If LN-229 is considered to contain mutant p53, there is a correlation that does not quite achieve statistical significance (p = 0.05, t-test). In contrast, these groups of cell lines did not differ with regard to invasion or the expression levels of MMP, ␣ V ␤ 3 , or of anti-or proapoptotic proteins. To evaluate the role of wild-type p53 in the migration of malignant glioma cells further, we examined U87MG and LN-229 cell lines that had been transfected with the dominant negative p53, mutant p53 val143 . 2 There was no significant difference in the ability of these transfected cells to penetrate uncoated membranes compared with that of control cells (U87MG neo 172 Ϯ 14; U87MG p53 val143 160 Ϯ 10; LN-229 neo 134 Ϯ 12; LN-229 p53 val143 126 Ϯ 9, three experiments, p Ͼ 0.05, t-test), indicating that inhibition of wild-type p53 function per se is not sufficient to inhibit migration.
Discussion
Multiple mechanisms underlying the striking migratory and invasive properties of malignant glioma cells have been proposed, including high levels of expression of ␣ V ␤ 3 integrin, MMP, and antiapoptotic BCL-2 family proteins. 10, 18, 24 Such studies were commonly performed with one or a few cell lines. In the present study, we examined a panel of 12 glioma cell lines, which previously had been analyzed for molecular genetic alterations predictive for chemosensitivity, 21 to define biochemical prerequisites for migration and invasion. A survey of distinct molecular alterations used to characterize these cell lines with respect to their histological characteristics, the age and sex of the patient, tumor location, p53 alterations, and PTEN, p14 ARF , and p16 status and growth in nu/nu mice has been published. 9 To this end, we assessed MMP mRNA and protein expression, MMP-2 and MMP-9 activities, ␣ V ␤ 3 integrin expression, and BCL-2 family protein expression, and correlated our findings with the migratory and invasive potentials of the 12 cell lines. Multiple MMPs were expressed by most cell lines (Fig. 1) . There was a good correlation between MMP-2, MT1-MMP, and TIMP-2 protein expression (Fig. 1B) in accordance with their proposed specific stoichiometric relations. FIG. 3 . Expression of the ␣ V ␤ 3 integrin and its requirement for glioma cell migration. A: Expression analysis for ␣ V and ␤ 3 mRNA was performed by RT-PCR with ␤-actin serving as a control for equal loading. Negative controls consisted of aliquots containing water instead of cDNA. B: The ␣ V ␤ 3 protein levels at the cell surface were quantified by flow cytometry. Compare the bold specific curve with the dotted curve obtained using an isotype-matched control antibody. C: Bar graph depicting the data shown in B after being quantified by calculating the specific fluorescence indexes for each cell line as the ratio of mean fluorescence intensity of cells stained with the specific antibody by the mean fluorescence intensity obtained using the control antibody. D and E: Bar graphs demonstrating tumor cell migration (D) and invasion (E), as determined in Fig. 2 , in the absence (black bars) or presence (open bars) of a neutralizing ␣ V ␤ 3 antibody (10 ng/ml). The degree of inhibition mediated by this antibody, compared with that of a control antibody, is expressed as residual migration or invasion in percentages. All experiments were performed at least three times.
All 12 cell lines examined in the present study were able to migrate and invade during the cell culture assays ( Fig. 2A and B) . Thus, neither ␣ V ␤ 3 integrin, which is absent from A172 and LN-319 cells, nor MMP-2 expression and activity, which are absent from LN-308 cells, are absolutely required for migration and invasion. The role of integrins in the motile phenotype of glioma cells has remained controversial because some authors have stressed the connection between integrin expression and cell adhesion, 6 whereas other authors have proposed an important influence on cell migration. 3, 5, 12 Although migration and invasion may be accomplished independently of ␣ V ␤ 3 integrin, as evidenced by A172 and LN-319 cells, a neutralizing ␣ V ␤ 3 integrin antibody effectively inhibited migration and invasion in cell lines that express the protein (Fig.  3D and E) , confirming that ␣ V ␤ 3 integrin is indeed an important part of the migration/invasion phenotype in a large subset of glioma cell lines. The functions of integrins can be negatively regulated by the recently discovered tumorsuppressor gene product PTEN, a protein homologous to protein tyrosine phosphatases and tensin. The PTEN gene is mutated in eight of the 12 cell lines examined in this study (U138MG, U87MG, D247MG, T98G, LN-319, U251MG, U373MG, and LN-308) 9 and has been shown to regulate sensitivity to irradiation and CD95L-induced apoptosis in the LN-229, U87MG, LN-308, and LN-18 cell lines. 23 The PTEN protein inhibits cell migration and invasion by directly dephosphorylating two key tyrosinephosphorylated proteins, focal adhesion kinase and phosphatidylinositol 3,4,5-trisphosphate, thereby antagonizing interactions of integrins with the extracellular matrix and integrin-triggered signaling pathways. 16 No correlation between the PTEN status and migration or invasion, however, became apparent in this study.
Interestingly, although the capacities to migrate and invade displayed a good correlation in these cell lines, specific patterns of MMP expression were selectively associated with invasion. In fact, MMP-2 and MMP-9 activities were the best predictors of invasive behavior in our analysis. Authors of future studies will need to corroborate the hypothesis proposed here that specific biochemical features determine glioma cell invasiveness as opposed to migration.
Expression of the human MMP-1 gene in sarcoma cells has been shown to be negatively controlled by p53. 15 In contrast, we found that cell lines retaining p53 activity were more active in the migration assay than mutant p53 cell lines, whereas no such effect was observed in the invasion assay. Abrogation of wild-type p53 function by the dominant negative mutant, p53 val143 , however, did not modulate migration, indicating that there is no direct link between wild-type p53 function and migration.
We recently documented a novel role for BCL-2 in maintaining a neoplastic phenotype in human glioma cell lines. 24 Ectopic expression of BCL-2 enhanced migration and invasion in LN-18 and LN-229 cells in an MMPdependent manner. Presumably, successful migration and invasion require resistance to endogenous apoptotic programs. At present, it remains unclear whether the promotion of migration and invasiveness is completely independent of the antiapoptotic properties of BCL-2. Strong antiapoptotic properties of BCL-2 in some cell lines examined here have been documented when these cells were challenged with cytotoxic CD95 antibody, chemotherapy, or irradiation. 20 Another antiapoptotic protein of the BCL-2 family, BAG-1, has been shown to accelerate migration in human gastric cancer cell lines. 11 An increased BCL-2/ BAX ratio has been associated with a migratory phenotype of glioma cells at the tumor margin. 18 Accordingly, our results show a significant correlation between migration and invasion of the 12 cell lines and the ratio of antiapoptotic to proapoptotic proteins (Fig. 4) . Thus, interfering with antiapoptotic BCL-2 family protein expression may not only result in enhanced sensitivity to therapeutic induction of apoptosis but may also directly interfere with major features of the neoplastic phenotype of glioma cells-that is, strong migratory and invasive properties.
Conclusions
In the present study, we examined 12 glioma cell lines, which had previously been characterized for molecular genetic alterations and chemosensitivity, 21 to define biochemical prerequisites for migration and invasion not in single cell lines but in a representative set of gliomas. We have analyzed metalloproteinases and inhibitors, integrins, and BCL-2 family proteins, and correlated these parameters with the motility of glioma cells. Activities of MMP-2 and MMP-9 are the best predictors of glioma cell invasion. The integrin ␣ V ␤ 3 mediates migration and invasion in a subset of glioma cell lines, but migration and invasion do not depend on the expression of ␣ V ␤ 3 integrin. Antiapoptotic BCL-2 family protein expression is a predictor of efficient migration and invasion.
